Saracatinib Trial tO Prevent FOP

Risultati finali

updated version if the data management plan

Initial Data management plan (DMP) adaptions will be made during the project lifespan these will be incorporated in updated versions of the DMP.

RCT registration in open access databases

RCT will be made public in databases with open access where possible

Exploitation plan

STOPFOP is expected to lead to various exploitable project results. Essential to the STOPFOP exploitation strategy is the timely identification of the project results that are potentially exploitable. At the consortium meetings, the Executive Board will be responsible for the identification of exploitable project results and for establishing a specific plan for exploitation.

Pubblicazioni

Protocol paper: a multi-center, double-blinded, randomized, 6-month, placebo-controlled study followed by 12-month open label extension to evaluate the safety and efficacy of Saracatinib in Fibrodysplasia Ossificans Progressiva (STOPFOP)

Autori: Bernard J Smilde, Clemens Stockklausner, Richard Keen, Andrew Whittaker, Alex N Bullock, Annette von Delft, Natasja M van Schoor, Paul B Yu, E Marelise W Eekhoff
Pubblicato in: BMC Musculoskeletal Disorders, Numero 23, 2022, Pagina/e 519, ISSN 1471-2474
Editore: BioMed Central
DOI: 10.1186/s12891-022-05471-x

Risultati finali

Pubblicazioni

Condividi questa pagina

Scarica